FEATURED

CAR-T Lentiviral Vector Expression Testing, Identity and Purity Assessment Throughout the Cell Therapy Manufacturing Process

A COLLABORATION BETWEEN ACCELLIX, NECSTGEN AND BIOMÉRIEUX

Oscar Bartulos1*, Jacob van Vloten2*, Félix Montero-Julian3, Melissa van Pel1, Christian Aguilera-Sandoval2
1NecstGen; 2Accellix; 3bioMérieux; *Co-first authors
Assay Reproducibility on the Accellix Platform
Method Comparison of the Accellix Platform vs Traditional Flow Cytometry
Comparing Cell Therapy Manufacturing QC Costs of Traditional Flow Cytometry vs the Accellix Platform
Cell therapy manufacturing: process analytic technologies needed to achieve flexible, feedback driven automation
Technical Evaluation of the Accellix Platform (Cell & Gene Therapy Insights)